Director/PDMR Shareholding

RNS Number : 0630E
Centrica PLC
25 October 2022
 

Centrica plc (the 'Company')

25 October 2022

Notification of Transactions of Directors

The Company was notified by Equiniti Financial Services Limited, that a Director acquired Centrica plc ordinary shares of 614/81 pence ('Shares') in accordance with their Share Purchase Agreement held with the Company.

The following notifications, made pursuant to Article 19 of the Market Abuse Regulation, provide further details.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Amber Rudd

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Centrica plc

b)

LEI

E26EDV109X6EEPBKVH76

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 6 14/81pence (Shares)

 

 

GB00B033F229

b)

Nature of the transaction

Acquisition of Shares in accordance with the Share Purchase Agreement entered into with the Company on 2 March 2022.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.686749

2,798

d)

Aggregated information

-  Aggregate Volume

-  Price

-  Total

 

2,798 Shares

£0.686749 per Share

£1,921.52

e)

Date of the transaction

25 October 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPGCPUUPPGPA

Companies

Centrica (CNA)
UK 100

Latest directors dealings